DowDuPont Inc has told India it is putting off trials needed for approval to sell a genetically modified variety of corn, taking a cue from US rival Monsanto that has also pulled a similar application due to intellectual property concerns.
In a letter addressed to India's environment ministry reviewed by Reuters, the Indian arm of DowDuPont said it had obtained permission to conduct trials growing a small crop of the corn in the northern state of Punjab but would like to "defer the undertaking". It did not give a reason for its decision.
"This is to confirm that we have deferred the Biosafety Research Level-I confined field trials with transgenic maize planned during the season of kharif 2018," a DowDuPont spokeswoman told Reuters in an email, referring to the summer planting season. "The company remains committed to advancing agricultural productivity in India."
She declined to give details. The decision to put off trials is not public. Monsanto, now a unit of Bayer AG, in 2016 withdrew an application seeking approval for its next generation of GM cotton seeds stung by a series of unfavourable government decisions.
Monsanto's transgenic cotton seeds has revolutionised the cotton industry in India, but the government has yet to allow the sale of GM food due to concerns over human and soil safety. But the trials of most GM crops are allowed, and DowDuPont's trial for its insecticide-resistant and herbicide-tolerant GM corn was in advanced stages of a lengthy and time-consuming process that often takes more than a decade.